New Report Demonstrates Big Pharma’s Abuses of the Patent System
Aug 2, 2018
CSRxP spokesman Will Holley released the following statement on the release of… Read More
© 2024 CSRXP- All Rights Reserved
Updates
High Priced Drugs Lead to Banner Q2 Earnings for Big Pharma
Jul 27, 2018
CSRxP released the following statement following a week of strong Q2 earnings… Read More
CSRxP on Lilly & Biogen Earnings
Jul 24, 2018
CSRxP released the following statement following the release of Eli Lilly and… Read More
CSRxP Applauds Admin Focus on Drug Prices
Jul 19, 2018
CSRxP spokesman Will Holley released the following statement applauding the… Read More
CSRxP Applauds FDA’s Biosimilars Action Plan
Jul 18, 2018
“We applaud Commissioner Gottlieb and the FDA for their leadership on… Read More
CSRxP Releases Comments on Drug Price Blueprint
Jul 13, 2018
The Department of Health and Human Services is taking a good first step in the… Read More
Statement on Celgene’s Revlimid Price Hike
Jul 10, 2018
CSRxP spokesman Will Holley released the following statement in response to… Read More
CSRxP Applauds Secretary Azar’s Focus on List Prices
Jun 26, 2018
CSRxP spokesman Will Holley released the following statement in response to… Read More
CSRxP Testimony for the Record: Senate Finance Committee Hearing on Rx Prices
Jun 25, 2018
The Campaign for Sustainable Rx Pricing today released testimony for the… Read More
CSRxP Applauds Senate Judiciary Committee for Vote on CREATES Act
Jun 14, 2018
“We applaud the members of the Senate Judiciary Committee for voting the… Read More
CSRxP Statement on Secretary Azar’s Testimony in Front of Senate HELP Committee
Jun 12, 2018
“When the manufacturer-set price of a drug starts out high… Read More
46 Signatories Applaud Grassley & Feinstein for CREATES Act Markup
Jun 7, 2018
46 organizations today applauded Chairman Chuck Grassley and Ranking Member… Read More